Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes
Joo Young Kim, Sun‐Hee Heo, Seul Ki Choi, et al.
Virchows Archiv (2017) Vol. 470, Iss. 4, pp. 381-389
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
Guoxuan Gao, Zihan Wang, Xiang Qu, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 172
Metabolic crosstalk in the breast cancer microenvironment
Ana S. Dias, Catarina R. Almeida, Luísa A. Helguero, et al.
European Journal of Cancer (2019) Vol. 121, pp. 154-171
Closed Access | Times Cited: 164
Metabolic reprogramming in triple-negative breast cancer
Zhanyu Wang, Qianjin Jiang, Chenfang Dong
Cancer Biology and Medicine (2020) Vol. 17, Iss. 1, pp. 44-59
Open Access | Times Cited: 141
The role of glutaminase in cancer
Brendah K. Masisi, Rokaya El Ansari, Lutfi Alfarsi, et al.
Histopathology (2019) Vol. 76, Iss. 4, pp. 498-508
Open Access | Times Cited: 144
Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer
Junfeng Zhang, Shiyu Mao, Yadong Guo, et al.
Bioscience Reports (2019) Vol. 39, Iss. 6
Open Access | Times Cited: 60
Metabolic reprogramming and disease progression in cancer patients
Laura Torresano, Cristina Nuevo‐Tapioles, Fulvio Santacatterina, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 5, pp. 165721-165721
Open Access | Times Cited: 60
Targeting the glutamine-arginine-proline metabolism axis in cancer
Di Wang, Jiang‐Jie Duan, Yufeng Guo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 8
Deciphering metabolic rewiring in breast cancer subtypes
Martin P. Ogrodzinski, Jamie J. Bernard, Sophia Y. Lunt
Translational research (2017) Vol. 189, pp. 105-122
Closed Access | Times Cited: 58
Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
Diane M. Demas, Susan D. Demo, Yassi Fallah, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 51
Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer
Chuanfan Zhong, Kaihui Wu, Shuo Wang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 8
Open Access | Times Cited: 28
Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer
Yang Yu, Xiaohui Yu, Chenling Fan, et al.
Journal of Molecular Medicine (2018) Vol. 96, Iss. 8, pp. 777-790
Closed Access | Times Cited: 34
Identification of cuproptosis-related gene CDKN2A as a molecular diagnostic target in gastric carcinoma based on transcriptomic data
Guo Chen, Wenli Zhang, D. M. Wei, et al.
Research Square (Research Square) (2025)
Open Access
Metabolomics as a tool for understanding and treating triple-negative breast cancer
Gyas Khan, Md Sadique Hussain, Sarfaraz Ahmad, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer
Roberto Corchado‐Cobos, Natalia García‐Sancha, Marina Mendiburu‐Eliçabe, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 322-322
Open Access | Times Cited: 15
Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer
Kishu Kitayama, Masakazu Yashiro, Tamami Morisaki, et al.
Cancer Science (2017) Vol. 108, Iss. 12, pp. 2462-2469
Open Access | Times Cited: 28
iTRAQ‐Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer
Zhen Jiang, Chenghua Zhang, Li Gan, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2018) Vol. 13, Iss. 4
Closed Access | Times Cited: 27
The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer
Brendah K. Masisi, Rokaya El Ansari, Lutfi Alfarsi, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 3963-3963
Open Access | Times Cited: 15
The Metabolic Landscape of Breast Cancer and Its Therapeutic Implications
Zhuoya Jiao, Yunxia Pan, Fengyuan Chen
Molecular Diagnosis & Therapy (2023) Vol. 27, Iss. 3, pp. 349-369
Closed Access | Times Cited: 6
Mitochondrial Plasticity and Glucose Metabolic Alterations in Human Cancer under Oxidative Stress—From Viewpoints of Chronic Inflammation and Neutrophil Extracellular Traps (NETs)
Hui-Ting Lee, Chen-Sung Lin, Chao‐Yu Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9458-9458
Open Access | Times Cited: 2
Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis
Demond Williams, Barbara Fingleton
Clinical & Experimental Metastasis (2019) Vol. 36, Iss. 3, pp. 211-224
Open Access | Times Cited: 17
Rhophilin-2 Upregulates Glutamine Synthetase by Stabilizing c-Myc Protein and Confers Resistance to Glutamine Deprivation in Lung Cancer
Dakai Xiao, Jiaxi He, Zhihua Guo, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 14
GLS1 is a Protective Factor in Patients with Ovarian Clear Cell Carcinoma and its Expression Does Not Correlate with ARID1A-mutated Tumors
Valentino Clemente, Asumi Hoshino, Mihir Shetty, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 8, pp. 784-794
Open Access | Times Cited: 10
Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy
Verra M. Ngwa, Deanna N. Edwards, Yoonha Hwang, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 7, pp. 694-705
Open Access | Times Cited: 6
Hormone-Glutamine Metabolism: A Critical Regulatory Axis in Endocrine-Related Cancers
Fengyuan Xu, Jialu Shi, Xueyun Qin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10086-10086
Open Access | Times Cited: 6
Functional characteristics of autophagy in pancreatic cancer induced by glutamate metabolism in pancreatic stellate cells
Lei Wang, Rongrong Bi, Lei Li, et al.
Journal of International Medical Research (2019) Vol. 48, Iss. 4, pp. 030006051986536-030006051986536
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top